Gestational trophoblastic disease (GTD) is a condition requiring regular monitoring of hormone human chorionic gonadotropin (HCG). The semi-quantitative method presented here is an alternative for monitoring in under-equipped environments. The illustration made from two clinical cases of GTD that we have followed shows that this method can be used in under-equipped settings and where the quantitative dosage is unavailable.

Gestational trophoblastic disease (GTD) is a condition requiring regular monitoring of hormone human chorionic gonadotropin (HCG). The semi-quantitative method presented here is an alternative for monitoring in under-equipped environments. The illustration made from two clinical cases of GTD that we have followed shows that this method can be used in under-equipped settings and where the quantitative dosage is unavailable.